Country profiles +
22 April 2015
Sheema Khan of Shapiro Cohen LLP provides an update on medical use claims in light of Canadian jurisprudence readmore

22 April 2015
India’s Section 3(d) is at it again, but the reasoning is sound, say Manisha Singh Nair and Zoya Nafis of LexOrbis readmore

22 April 2015
What changes to Russian IP legislation came into force on 1 October 2014, and why? Maria Nilova and Elena Dmitrenko of Patentica LLP take a look readmore

25 February 2015
Opposing an application through the patent office is standard these days, isn’t it? readmore

28 January 2015
Gene patenting is again an issue for courts, this time in Canada readmore

11 December 2014
The Off-Patent Drugs Bill is receiving support from pharmaceutical bodies and companies, but a disagreement between politicians threatens to derail it readmore

FIRST << 1 2 3 4 5 >> LAST

FaceBook LinkedIn RSS feed Blog Instagram Twitter
Specialist features +
Interviews ++
Latest news +++
Matters of import
20 January 2016
Alireza Behrooz of Merchant & Gould and Nick Phillips of Edwin Coe discuss parallel importation of pharmaceuticals in the US and Europe readmore

Raising the bar
16 December 2015
Amendments to the US Civil Rules of Procedure could dissuade some non-practicing entities from targeting technology-rich sectors readmore

Making connections
02 December 2015
Changes are coming to the UK Patent Box to meet new international standards readmore

More features
Terry Mahn
Fish & Richardson
03 February 2016
Terry Mahn of Fish & Richardson discusses the issues still to be resolved in the Food and Drug Administration’s proposed naming system for biosimilars readmore

Rogelio Nicandro
Romulo LLP
04 November 2015
Rogelio Nicandro of Romulo LLP offers some handy tips for stopping trademark infringement in the Philippines readmore

Grant Shoebridge
Shelston IP
04 November 2015
Grant Shoebridge of Shelston IP unpacks the Australian High Court’s Myriad decision readmore

More interviews
AstraZeneca enters China with Plendil
02 March 2016 | London
AstraZeneca has entered into a licensing agreement with China Medical System (CMS) Holdings for the commercialisation rights in China to its calcium channel blocker, Plendil (felodipine)... readmore

Hogan Lovells boosts capabilities in Japan
01 March 2016 | Tokyo
Hogan Lovells has boosted its Japanese domestic patent capability with the hire of Hiroto Imai... readmore

Morgan Lewis bags four from K&L Gates
29 February 2016 | Chicago
Morgan Lewis has expanded its global IP team with four new partners from K&L Gates... readmore

More news

IPPro Life Sciences


Copyright (C) 2013 Black Knight Media Ltd. All rights reserved. No reproduction without prior authorization